ReviewBreast cancer (Dove Medical Press)2026
Nanomedicine-Based Strategies Targeting Macrophage Polarization in Breast Cancer Bone Metastasis: An Updated Review.
Review in Breast cancer (Dove Medical Press), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The presence of bone metastasis represents one of the common and toughest complications of breast cancer that significantly increases the morbidity rate. Currently available therapies for treating breast cancer have been able to ameliorate symptoms, but still suffer from insufficient accumulation of the drugs in bone metastatic sites and severe side effects on the whole body. The use of drug delivery systems based on nanomedicine has been demonstrated to be a promising approach in improving drug accumulation and pharmacodynamics of drugs in pre-clinical models. Engineered nanoparticles could be tailored in order to improve accumulation in the tumor environment and provide the delivery of drugs to bone metastatic regions. Moreover, recent advances in nanotechnology have provided many new options for imaging and therapeutic experiments in metastatic cancers. Modulation of tumor‑associated macrophage (TAM) polarization represents one of the recently described strategies since M2-like phenotype contributes to tumor growth, immunosuppression and metastasis development, while induction of M1-like phenotype has been proven to be effective in enhancing anti-tumor immune response in pre-clinical models. In this review, we discuss recent advances in the nanomedicine approach that targets TAM polarization in breast cancer bone metastasis, the rationale of the proposed strategies, therapeutic potential and limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.